STOCK TITAN

Enhabit (NYSE: EHAB) EVP receives stock grant, shares withheld for taxes

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enhabit, Inc. executive Jeanne Louise Kalvaitis, EVP of Hospice Operations, reported routine equity compensation and related tax withholding transactions in company common stock. On March 6, 2026, she received a grant/award of 5,603 shares at $13.61 per share, increasing her direct holdings to 57,351 shares. That same day, 1,365 shares were disposed of at $13.61 per share to satisfy tax withholding obligations tied to vesting restricted stock, as noted in the footnote. On March 7, 2026, a further 835 shares were similarly disposed of at $13.61 per share for tax withholding. After these compensation-related transactions, Kalvaitis directly holds 55,151 shares of Enhabit common stock. These dispositions reflect tax payments rather than open-market trading activity.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kalvaitis Jeanne Louise

(Last) (First) (Middle)
6688 N. CENTRAL EXPRESSWAY
SUITE 1300

(Street)
DALLAS TX 75206

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Enhabit, Inc. [ EHAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP of Hospice Operations
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/06/2026 A 5,603 A $13.61 57,351 D
Common Stock 03/06/2026 F 1,365(1) D $13.61 55,986 D
Common Stock 03/07/2026 F 835(1) D $13.61 55,151 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.
Remarks:
/s/ Sarah W. Braley, Attorney in Fact 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Enhabit (EHAB) report for Jeanne Louise Kalvaitis?

Enhabit reported that EVP of Hospice Operations Jeanne Louise Kalvaitis received a grant of 5,603 common shares and had 2,200 shares disposed of to cover tax withholding obligations. After these transactions, she directly holds 55,151 Enhabit common shares.

Were the Enhabit (EHAB) insider share dispositions open-market sales?

The reported share dispositions were not open-market sales. They were shares withheld or surrendered to satisfy Jeanne Louise Kalvaitis’s tax withholding obligations related to vesting restricted stock, according to the footnote, which characterizes them as tax-withholding events rather than discretionary trading.

How many Enhabit (EHAB) shares did Jeanne Louise Kalvaitis receive in the latest grant?

Jeanne Louise Kalvaitis received a grant or award of 5,603 Enhabit common shares on March 6, 2026, at a reported value of $13.61 per share. This grant increased her direct holdings before subsequent tax-withholding share dispositions reduced the total.

What is Jeanne Louise Kalvaitis’s Enhabit (EHAB) share ownership after the Form 4 transactions?

Following the reported grant and tax-withholding dispositions, Jeanne Louise Kalvaitis directly owns 55,151 shares of Enhabit common stock. This figure reflects her position after both the 5,603-share compensation award and the combined 2,200 shares disposed of for tax obligations.

On what dates did the Enhabit (EHAB) insider transactions for Jeanne Louise Kalvaitis occur?

The Form 4 shows transactions on March 6 and March 7, 2026. On March 6, she received a share grant and had shares disposed for taxes, followed by an additional tax-withholding disposition on March 7, all at a reported price of $13.61 per share.
Enhabit

NYSE:EHAB

View EHAB Stock Overview

EHAB Rankings

EHAB Latest News

EHAB Latest SEC Filings

EHAB Stock Data

689.84M
48.91M
Medical Care Facilities
Services-home Health Care Services
Link
United States
DALLAS